With plans to sell 60 million shares of common stock, Bright Health will price its IPO between $20 and $23 per share. It will trade on the New York Stock Exchange under the symbol “BHG,” according to a recent SEC filing.
In Venrock’s annual survey of healthcare leaders, respondents expected most digital health startups that went public during the pandemic to see their valuations fall by the end of the year.
California biotech Ambrx Biopharma is hoping to raise $126 million from a listing on the New York Stock Exchange (NYSE) that will be used in part to fund clinical development of ARX-788, its HER2-targeting antibody drug conjugate (ADC). The Scripps Research spinout could be just… Read More »Ambrx tries another IPO as it chases down HER2 rivals
Doximity, the “LinkedIn for physicians,” is preparing for an IPO. In an unusual move, it’s setting aside a portion of its shares for some of its users.
Arecor Therapeutics is planning to float on the London stock market, to raise funding and awareness for its developmental portfolio of biologic drugs, which are based on already-marketed drugs reformulated to provide extra benefits for patients. Arecor Therapeutics is the latest company aiming to take… Read More »Arecor heads for London Stock Exchange with drug reformulation strategy
Bright Health has filed preliminary paperwork for an IPO, joining its rivals in the insurance technology space in going public. Though there are few confirmed details at the moment, Bright Health is reportedly looking to raise $1 billion through the offering.
Vera Therapeutics raised $47.9 million from its IPO to continue clinical development of its lead asset, a potential treatment for the kidney disease IgA nephropathy. But the company is joining a crowded field of companies aiming to develop a drug for the rare disorder.
In a wide-ranging interview, Privia Health CEO Shawn Morris discussed the company’s recently closed IPO, its plans for the funds raised and what he sees as the company’s biggest value-add as the Covid-19 pandemic enters a new phase.
Today on Health in 2 Point 00, Jess hardly knows the value of $100 million anymore – is it a salary, is it an entire fund, is it one single round? On Episode 203, Jess and I cover Vocera buying PatientSafe Solutions and Privia going… Read More »#Healthin2Point00, Episode 203 | Privia goes public, Vocera acquires PatientSafe Solutions & more
The physician practice management company launched its IPO through which it plans to sell 19.5 million shares of common stock, priced between $17 and $19 per share. It will use the proceeds for general corporate purposes, like research and development, and to acquire complementary businesses… Read More »Privia Health launches IPO, aims to raise up to $370M
By JESSICA DaMASSA, WTF HEALTH Sharecare, the population-health-slash-care-navigator of the stars (literally, celebrity doc Dr. Oz is a co-founder, and Oprah’s Harpo Productions, Sony Pictures Television, and Discovery Communications are partners) is about to hit the public market via a $4-Billion SPAC IPO with Falcon… Read More »Sharecare’s SPAC IPO: A Second Success for WebMD Founder Jeff Arnold?
Centessa has announced plans for a $100m US IPO just weeks after the company launched with $250m in private backing and an R&D powerhouse driven by the merger of 10 biotechs. In a filing with the Securities and Exchange Commission, Centessa said it plans to… Read More »Centessa plans $100m IPO to fund R&D and potential acquisitions
– Today Benchling, the leading life and sciences R&D cloud, announced a $200M Series E raise led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital, and Elad Gil. This funding will be used to aggressively invest in product development and global… Read More »Led by Sequoia, Benchling Raises $200M to Accelerate R&D Cloud Platform
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the… Read More »Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
VillageMD, a primary care startup that has Walgreens as a big backer, is reportedly planning to go public. The company has plans to open hundreds of co-located primary care clinics at Walgreens pharmacies.
UK biotech Achilles Therapeutics has completed its initial public offering (IPO) in the US, raising $175.5 million that will be used to take its personalised T cell therapy for lung and skin cancers through proof-of-concept trials. The new funding will also be used to advance… Read More »Cancer Research UK spinout Achilles raises $175.5m in IPO
Insurance startup Bright Health is reportedly planning to raise up to $1 billion in an IPO that will be launched in the second quarter of 2021. The company, which provides several insurance products as well as an IT platform, could be valued at more than… Read More »Report: Bright Health eyes $1B IPO
Peter Meath, J.P. Morgan Commercial Banking’s Co-Head of Healthcare and Life Sciences, applies lessons from 2020’s remarkable second half and shares insights on what to expect in 2021.
Alignment Healthcare, an insurtech startup, has launched its IPO and plans to price its individual shares between $17 and $19. The company offers Medicare Advantage plans and says it uses predictive analytics technology to pinpoint seniors’ care needs.
By JESSICA DaMASSA, WTF HEALTH Oh Baby! Connected digital nursery startup, Owlet Baby Care, just announced their SPAC IPO and intention to take their infant smart sock from baby monitor to FDA-approved medical device. I talk with Owlet’s co-founder & CEO, Kurt Workman, to find… Read More »Inside Owlet’s SPAC IPO: From Smart Sock Baby Monitor to Data-Driven Pediatric Healthcare Co
Insurance startup Alignment Healthcare filed preliminary paperwork with the Securities and Exchange Commission to go public. It’s another healthcare startup that is banking on the value of its technology in an IPO.
Insurance startup Oscar Health plans to price its IPO between $32 and $34 per share. The New York-based startup plans to trade on the New York Stock Exchange under the ticker “OSCR.”
Digital health startup Sharecare plans to go public through a merger with a blank-check company created by Alan Mnuchin. The deal will value the company at $3.9 billion.
What You Should Know: – Digital health company Sharecare and special purpose acquisition company (SPAC), Falcon Capital Acquisition Corp, today announced an agreement to merge to go public on the NASDAQ under the ticker symbol SHCR at enterprise value of $3.9B. – The transaction is… Read More »Sharecare to Go Public in SPAC IPO Deal, Reaching $3.9B Valuation
Signify Health, a company that provides services for value-based care programs, went public on Thursday in an upsized IPO. The company’s stock began trading at $24 per share, above its expected range of $20 to $21 per share.
What You Should Know: – Shares of Signify Health, a value-based care billing platform for in-home and bundled health services jumped more than 33% in its initial public offering (IPO), valuing the company at over $7.12B. – Today, Signify Health’s CEO Kyle Armbrester will also… Read More »Signify Health Shares Soar More Than 33% in IPO, Valuing Company at Over $7.12B
Consumer DNA testing company 23andMe plans to go public through a merger with a special-purpose acquisition company started by Virgin Group. As sales of DNA testing kits wane, how will 23andMe drum up new interest for its business?
Walgreens appoints Rosalind (Roz) Brewer as the company’s Chief Executive Officer, effective on March 15, 2021. Brewer will also join the WBA Board of Directors upon assuming the role. She succeeds Stefano Pessina who, as previously announced, will transition to the role of Executive Chairman… Read More »Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others
Compute Health Acquisition Corp Chairman Omar Ishrak What You Should Know: – Compute Health Acquisition, a SPAC company targeting the intersection of computation and healthcare announced the pricing of its $750M initial public offering (IPO) by offering 75 million units at $10. Compute Health Acquisition… Read More »SPAC Compute Health Acquisition Prices $750M IPO, Led by Intel Chairman
Sana Biotechnology is turning new science into novel medicines intended to overcome limitations of current cell therapies. After going from stealth to IPO in two years, it’s now planning to bring multiple programs into clinical testing in 2022.
What You Should Know: – Casana raises $14M in Series A funding to pursue FDA clearance for its an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output. Casana, previously known as Heart Health… Read More »Casana Raises $14M to Expand IoT Heart Health Toilet Seat
New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the… Read More »UK biotech investment at record levels amid COVID-19
Direct-to-consumer health startup Ro is reportedly in talks go public through a merger with a blank-check company, according to a report by Reuters.
Sharecare, a digital health startup created by Web MD founder Jeff Arnold and Dr. Mehmet Oz, is reportedly in talks to go public through a merger with a special-purpose acquisition company. It also recently acquired startup Doc.ai.
The three-year-old digital health startup began trading on the New York Stock Exchange on Thursday. It merged with a subsidiary of Oaktree Capital Management in a deal that valued the company at $1.6 billion.
Signify Health, a startup that provides in-home healthcare services and value=based payment programs, filed early paperwork for an IPO. The company plans to be traded on the New York Stock Exchange under the ticker “SGFY.”
The digital therapy provider plans to go public through a blank-check acquisition by Hudson Executive Capital. The deal would value Talkspace at $1.4 billion and provide $250 million in capital.
On the heels of a $140 million funding round, insurance startup Oscar Health confidentially filed for an IPO.
AbCellera Biologics has been in the spotlight since coming up with Eli Lilly’s COVID-19 antibody drug bamlanivimab, and looks set to capitalise on that exposure with a sizeable initial public offering. The Vancouver, Canada-headquartered biotech – which has been bankrolled in part by billionaire entrepreneur… Read More »AI drug discovery biotech AbCellera eyes record IPO
What You Should Know: – Israeli-based G Medical Innovation has withdrawn its plans for an initial public offering (IPO) on Tuesday, Nasdaq first reports. – The company originally filed an IPO to raise $30 million by offering 5 million shares at a price range of… Read More »Israeli Digital Health Startup G Medical Innovations Withdraws $30M US IPO
By JESSICA DaMASSA, WTF HEALTH When Accolade went public in July at a $1.2B valuation, the BIG question facing the health tech unicorn pre-dated the covid-19 pandemic and the chaos facing its clientbase of large, self-insured employers: Could they scale? Raj Singh, Accolade’s CEO, tackles… Read More »Accolade’s CEO Raj Singh: IPO Backstory & Pop Health Predictions for 2021
The company, which offers a remote scribe services, secured $25 million in private placement financing and began trading publicly on the OTC markets after a reverse merger with Malo Holdings.
When it announced plans to go public through a blank-check company, Clover Health shared ambitious projections for its future membership. Much of that growth is pinned on plans to launch a direct contracting business.
Today on Health in 2 Point 00, Jess and I gossip about the wild rumor that UnitedHealthcare is acquiring Amwell. On Episode 157, we discuss Lark raising $55 million in a Series C along with a deal with Anthem to be their preferred DPP provider,… Read More »#Healthin2Point00, Episode 157 | The phrase is “Takeout Speculation”!
The direct-to-consumer telehealth startup will go public through a merger with special purpose acquisition company Oaktree Acquisition Corp. The combined entity is expected to be valued at $1.6 billion.
GoodRx, a digital health startup that helps users track prescription drug prices, filed for an IPO on Friday. The company hasn’t yet priced its shares, but plans to be listed on Nasdaq as “GDRX.”
Amwell filed preliminary paperwork for an IPO. The telehealth company also struck a partnership with Google, which will buy $100 million of its class C common stock.
Outset Medical, a San Jose-based company making portable dialysis machines, filed the initial paperwork for an IPO. The company has not yet set a price range for its stock, but said it plans to raise roughly $100 million.
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of July 2020. While a pandemic ravages the country, technology valuations are soaring. The Nasdaq hit an all-time high during the month of… Read More »Analysis: July Health IT M&A Activity; Public Company Performance
What You Should Know: – Siemens Healthineers and Varian Medical announce a $16.4B deal in an all-cash transaction on 2nd August 2020. – Deal expected to close in 1H 2021. – Varian Medical will maintain its brand name and operate “independently” – Siemens AG will… Read More »M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical
Oak Street Health, which operates primary care centers for Medicare patients, went public on Thursday for $328 million. Its capitation payment model has helped the company continue on where many clinics have struggled during the Covid-19 pandemic.
GoodRx, a startup that makes tools for comparing the price of prescription drugs, is looking to go public, according to a report by Reuters. The company reportedly submitted paperwork to the Securities and Exchange Commission.
US biotech Inozyme Pharma is the latest to jump on to the IPO bandwagon, setting terms for a $75 million stock market launch, as the firm gears up for clinical trials of its lead drug for rare bone diseases. Based in Boston, Massachusetts, the company… Read More »Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug
Healthcare Growth Partners, an Investment Banking and Strategic Advisory firm exclusively focused on the transformational health IT market, today announced the release of its Semi-Annual Health IT Market Review report that summarizes M&A and private equity activity across health IT, health information services, and digital health.… Read More »HGP Semi-Annual Health IT Market Review: 6 Key Trends to Know
GoHealth, an online insurance broker focusing on Medicare Advantage plans, went public on Wednesday for $914 million. The company will trade on Nasdaq under the ticker “GOCO.”
Oak Street Health, a Chicago-based company that operates primary care centers for Medicare patients, filed initial IPO paperwork on Friday. The company has not yet priced the offering, but it plans to use the proceeds to repay a loan and grow its business.
Today on Health in 2 Point 00, Jess and I cover some big news! Accolade has filed its IPO, so on Episode 132 I give my take on this health care navigation service. We also cover Somatus getting $64 million for chronic kidney disease care,… Read More »